1. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J (1981) Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The Transfusion-Transmitted Viruses Study. New Engl J Med 304:989–994.
2. Alter HJ (1984) Resolved and unresolved issues in non-A, non-B hepatitis. In: Williams R, Mad-drey WC (eds) Butterworths International Medical Reviews Gastroenterology 4: Liver, Butter-worths, London, pp 165–190.
3. Alter HJ (1985) Posttransfusion hepatitis: Clinical features, risk and donor testing. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol. 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 47–61.
4. Anonymous (1986) Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III, lymph-adenopathy-associated virus infection. MMWR 35/14:231–233.
5. Barbara J, Salker R, Lalji F, Mochnaty P (1982) TPHA compared with cardiolipin tests for serological detection of early primary syphilis. J Clin Path 35:1394–1395.